AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Declaration of Voting Results & Voting Rights Announcements May 14, 2020

5328_dva_2020-05-14_74bc5716-c5be-44f6-8fcc-b2a4b454ba0f.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9449M

Spire Healthcare Group PLC

14 May 2020

SPIRE HEALTHCARE GROUP PLC (the 'Company')                                          14 May 2020

Results of 2020 Annual General Meeting

At the sixth annual general meeting of the Company held at 9.00am today at 3 Dorset Rise, London EC4Y 8EN, all resolutions were passed on a poll. The polling results for each resolution are set out below:

RESOLUTION VOTES

FOR
% VOTES

AGAINST
% % of ISC VOTED VOTES

WITHHELD
1 Receive and adopt the 2019 Annual Report and Accounts 314,583,465 100.00 11,546 0.00 78.44% 803,870
2 Approve the 2019 Directors' Remuneration Report 277,089,976 99.71 796,110 0.29 69.28% 37,512,795
3 Re-elect Adèle Anderson 314,820,596 99.82 570,793 0.18 78.64% 6,778
4 Re-elect Martin Angle 314,127,595 99.60 1,262,817 0.40 78.64% 7,755
5 Re-elect Justin Ash 314,732,082 99.79 663,567 0.21 78.64% 2,518
6 Re-elect Tony Bourne 314,537,950 99.73 849,071 0.27 78.63% 11,146
7 Re-elect Dame Janet Husband 314,541,262 99.73 850,127 0.27 78.64% 6,778
8 Re-elect Simon Rowlands 314,727,321 99.79 659,700 0.21 78.63% 11,146
9 Re-elect Jitesh Sodha 314,486,499 99.71 904,389 0.29 78.64% 7,279
10 Re-elect Garry Watts 314,727,822 99.79 660,176 0.21 78.63% 10,169
11 Re-elect Dr. Ronnie van der Merwe 312,669,221 99.14 2,718,276 0.86 78.63% 10,670
12 Elect Jenny Kay 314,865,831 99.83 522,167 0.17 78.63% 10,169
13 Reappointment of Ernst & Young LLP as auditors 314,763,824 99.80 634,920 0.20 78.64% 137
14 Authorise the Directors' to determine the auditor's remuneration 315,366,703 99.99 28,461 0.01 78.64% 3,717
15 Authorise political expenditure 314,529,993 99.73 864,099 0.27 78.64% 4,789
16 Renew the authority to allot shares 306,838,196 97.29 8,551,859 2.71 78.63% 8,826
17 Renew the authority to disapply statutory pre-emption rights* 313,668,344 99.45 1,727,426 0.55 78.64% 3,111
18 Renew the authority to disapply statutory pre-emption rights for an acquisition or specified capital investment* 313,058,843 99.26 2,332,382 0.74 78.64% 7,656
19 Authorise the Company to purchase its own shares* 314,444,282 99.71 905,058 0.29 78.62% 49,541
20 Authorise general meetings, other than annual general meetings, to be held on 14 clear days' notice* 309,580,759 98.16 5,813,344 1.84 78.64% 17

*Special Resolution

A trading update was released by the Company at 7.00am this morning.

Notes:

i)          Any proxy appointments which gave discretion to the Chairman have been included in the "for" total.

ii)          The total number of shares in issue (ISC) is 401,081,391.

iii)         A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "for" and "against" a resolution.

iv)         All percentages are shown to two decimal places.

This information will also shortly be available to view on the Company's website at: www.spirehealthcare.com.

Copies of the resolutions dealing with special business passed at the Annual General Meeting have been sent to the National Storage Mechanism and will shortly be available for inspection.

Philip Davies

Interim Company Secretary

14 May 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RAGSFUFFLESSELI

Talk to a Data Expert

Have a question? We'll get back to you promptly.